Charles River Laboratories International, Inc. (CRL) Receives...


Shares of Charles River Laboratories International, Inc. have received an average recommendation of "Buy" from the eleven ratings firms that are currently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company.



from Biotech News